Home

Inadequate response

Depression, Schizophrenia

Read time: 4 min

Satellite symposium

Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning

Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In...

Read time: 3 min

Congress highlights

Real world evidence for CGRP antibodies in migraine prevention

In a topical symposium at #EAN2021, three speakers discussed what is new on targeting CGRP for...

Read time: 3 min

Satellite symposium

Potential treatment options for trauma-associated depression and emotional blunting

Mass traumatic events, such as the global COVID-19 pandemic, significantly impact on mental health...

Read time: 3 min

Congress highlights

If at first you don’t succeed, try another CGRP antibody for migraine prevention?

If the first monoclonal antibody targeting calcitonin gene-related peptide fails to adequately...

Read time: 3 min

Satellite symposium

Promising data in depression associated with emotional blunting or trauma

Treatment for depression should be tailored to individuals’ history and presentation....

Read time: 2 min

Why do antidepressants cause emotional blunting and what can be done to resolve it in clinical practice?

Emotional blunting describes an indifferent, unresponsive affect and inability to feel emotions...

Read time: 3 min

Satellite symposium

Beyond symptom reduction and towards engagement with life

Enhancing engagement with life is a key target of treatment in MDD and extends beyond symptom...

Read time: 3 min

Congress highlights

A patient’s voice: hearing the true impact of chronic migraine

In this engaging satellite symposium from EAN2021 virtual, Professor Dawn Buse (Albert Einstein...

Read time: 2 min

Congress highlights

Reconceptualising treatment-resistant depression as difficult-to-treat depression

Treatment-resistant depression is a concept that needs to be clinically re-defined to encompass a...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country